L Peng

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. pmc Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum
    Lan Peng
    Department of Pathology and
    Rare Tumors 4:e20. 2012
  2. pmc A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature
    Sasan Mirfakhraee
    Department of Internal Medicine, Division of Endocrinology and Metabolism, The University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA
    Thyroid Res 6:7. 2013
  3. ncbi request reprint Pancreatic neuroendocrine tumors: signal pathways and targeted therapies
    L Peng
    Department of Pathology, UT Southwestern Medical Center, 5909 Harry Hines Boulevard, Dallas, TX 75390 9234, USA
    Curr Mol Med 13:333-9. 2013

Collaborators

Detail Information

Publications3

  1. pmc Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum
    Lan Peng
    Department of Pathology and
    Rare Tumors 4:e20. 2012
    ..Such tumor is very rare and may thus provide diagnostic challenges. This report also provides a review of other cases on duodenal collision tumors...
  2. pmc A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature
    Sasan Mirfakhraee
    Department of Internal Medicine, Division of Endocrinology and Metabolism, The University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA
    Thyroid Res 6:7. 2013
    ..Also, FTC and Hurthle cell carcinoma are found more frequently in hot nodules than in general. We were unable to find any specific characteristics that could be used to distinguish between malignant and benign hot nodules...
  3. ncbi request reprint Pancreatic neuroendocrine tumors: signal pathways and targeted therapies
    L Peng
    Department of Pathology, UT Southwestern Medical Center, 5909 Harry Hines Boulevard, Dallas, TX 75390 9234, USA
    Curr Mol Med 13:333-9. 2013
    ..Biologic therapy through targeting relevant pathways represents a promising approach in the therapy of advanced and unresectable PNETs...